Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Appointed director
Quarterly results
Foundation Medicine, Inc. (FMI) Create: Alert

All | News | Filings
Date FiledTypeDescription
07/31/2018 8-K Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Fa...
Docs: "Amended and Restated Certificate of Incorporation of the Company (filed herewith)",
"Bylaws of the Company (filed herewith)"
06/21/2018 8-K Submission of Matters to a Vote of Security Holders
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 of The Securities Exchange Act of 1934 Date of Report : June 21, 2018 Foundation Medicine, Inc. Delaware 001-36086 27-1316416 150 Second Street Cambridge, MA 02141 Registrant's telephone number, including area code 418-2200 Not Applicable Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act ☐ Pre-commencement communications pursuant to Rule 14d-2 under the Exchange Act ) ☐ Pre-commenceme..."
06/19/2018 8-K Quarterly results
06/07/2018 8-K Entry into a Material Definitive Agreement
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 of The Securities Exchange Act of 1934 Date of Report : June 6, 2018 Foundation Medicine, Inc. Delaware 001-36086 27-1316416 150 Second Street Cambridge, MA 02141 Registrant's telephone number, including area code 418-2200 Not Applicable"
05/02/2018 8-K Quarterly results
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 of The Securities Exchange Act of 1934 Date of Report : May 2, 2018 Foundation Medicine, Inc. Delaware 001-36086 27-1316416 150 Second Street Cambridge, MA 02141 Registrant's telephone number, including area code 418-2200 Not Applicable Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act ☐ Pre-commencement communications pursuant to Rule 14d-2 under the Exchange Act ) ☐ Pre-commencement...",
"Foundation Medicine Announces 2018 First Quarter Results and Recent Highlights"
03/19/2018 8-K Other Events, Financial Statements and Exhibits
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 of The Securities Exchange Act of 1934 Date of Report : March 16, 2018 Foundation Medicine, Inc. Delaware 001-36086 27-1316416 150 Second Street Cambridge, MA 02141 Registrant's telephone number, including area code 418-2200 Not Applicable Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act ☐ Pre-commencement communications pursuant to Rule 14d-2 under the Exchange Act ) ☐ Pre-commencem...",
"Foundation Medicine Announces Final National Coverage Determination from the Centers for Medicare & Medicaid Services , Including Coverage for FoundationOne CDx™ Across All Solid Tumors"
03/07/2018 8-K Quarterly results
Docs: "Foundation Medicine Announces 2017 Fourth Quarter and Year-End Results, Recent Highlights and 2018 Outlook"
03/05/2018 8-K Entry into a Material Definitive Agreement
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 of The Securities Exchange Act of 1934 Date of Report : February 28, 2018 Foundation Medicine, Inc. Delaware 001-36086 27-1316416 150 Second Street Cambridge, MA 02141 Registrant's telephone number, including area code 418-2200 Not Applicable"
01/08/2018 8-K Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Foundation Medicine Reports Preliminary 2017 Results",
"Presentation Slide Deck, furnished hereto"
12/19/2017 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Q"
12/01/2017 8-K Other Events, Financial Statements and Exhibits
Docs: "FDA Approves Foundation Medicine’s FoundationOne CDx™, the First and Only Comprehensive Genomic Profiling Test for All Solid Tumors Incorporating Multiple Companion Diagnostics"
11/01/2017 8-K Quarterly results
Docs: "Foundation Medicine Announces 2017 Third Quarter Results and Recent Highlights"
10/10/2017 8-K Quarterly results
09/13/2017 8-K Quarterly results
06/21/2017 8-K Form 8-K - Current report
05/09/2017 8-K Form 8-K - Current report
04/12/2017 8-K Form 8-K - Current report
03/02/2017 8-K Form 8-K - Current report
02/22/2017 8-K Form 8-K - Current report
01/09/2017 8-K Form 8-K - Current report
01/06/2017 8-K Form 8-K - Current report
12/20/2016 8-K Form 8-K - Current report
11/02/2016 8-K Form 8-K - Current report
10/28/2016 8-K Form 8-K - Current report
10/05/2016 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "Third Amendment to Lease, by and between Foundation Medicine, Inc., as tenant and ARE-MA Region No. 50, LLC, as landlord",
"Consent to Assignment, by and among ARE-MA Region No. 50, LLC, bluebird bio, Inc., and Foundation Medicine, Inc.",
"Assignment and Assumption of Lease, by and between Foundation Medicine, Inc. and bluebird bio, Inc."
08/02/2016 8-K Form 8-K - Current report
06/22/2016 8-K Submission of Matters to a Vote of Security Holders
05/03/2016 8-K Form 8-K - Current report
04/12/2016 8-K Form 8-K - Current report
03/28/2016 8-K Form 8-K - Current report
02/23/2016 8-K Quarterly results
Docs: "Foundation Medicine Announces 2015 Fourth Quarter and Year-End Results, Recent Highlights and 2016 Outlook"
01/11/2016 8-K Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Foundation Medicine Reports Preliminary 2015 Results and Provides 2016 Business Outlook, including Commercial Launch of its ctDNA Assay",
"Presentation Slide Deck"
11/03/2015 8-K Quarterly results
Docs: "Foundation Medicine Announces 2015 Third Quarter Results and Recent Highlights Year-over-Year Third Quarter Revenues Grow 54%; FoundationCORE™ Expands to Approximately 60,000 Patient Cases; ctDNA Product Launch on Track"
07/29/2015 8-K Quarterly results
Docs: "Foundation Medicine Announces 2015 Second Quarter Results and Recent Highlights Year-over-Year Revenues Grow 55%; FoundationCORE™ Expands to More Than 50,000 Patient Cases; Guidance Updated for 2015"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy